Insider Trading Activity For Sienna Biopharmaceuticals Inc (NASDAQ:SNNA)

Keith R Leonard , Director of Sienna Biopharmaceuticals Inc (NASDAQ:SNNA) reportedly Bought 16,700 shares of the company’s stock at an average price of 15 for a total transaction amount of $250,500.00 SEC Form

Analyst Ratings For Sienna Biopharmaceuticals Inc (NASDAQ:SNNA)
These are No ratings tracked in the last 12 months. .
The current consensus rating for Sienna Biopharmaceuticals Inc (NASDAQ:SNNA) is N/A (Score: NaN) with a consensus target price of N/A

Recent Trading Activity for Sienna Biopharmaceuticals Inc (NASDAQ:SNNA)
Shares of Sienna Biopharmaceuticals Inc closed the previous trading session at with 76,663 shares trading hands.